Editorial Article
Multidisciplinary approaches optimize contract drug discovery
Learn how a US company is changing the paradigm for contract research, combining disease pharmacology, toxicology, and pathology to optimize drug development
Learn how a US company is changing the paradigm for contract research, combining disease pharmacology, toxicology, and pathology to optimize drug development
STAG will act as an internal funding body for promising research; develop new assays and technologies alongside customers; and attract the next generation of scientists
Scientific findings establish the effectiveness of Envigo’s new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection